293 related articles for article (PubMed ID: 31974906)
1. TAAR1 and Psychostimulant Addiction.
Liu J; Wu R; Li JX
Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
[TBL] [Abstract][Full Text] [Related]
2. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.
Liu JF; Li JX
Front Pharmacol; 2018; 9():279. PubMed ID: 29636691
[TBL] [Abstract][Full Text] [Related]
3. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
4. Trace amine-associated receptor 1 and drug abuse.
Wu R; Liu J; Li JX
Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
[TBL] [Abstract][Full Text] [Related]
5. TAAR Agonists.
Xu Z; Li Q
Cell Mol Neurobiol; 2020 Mar; 40(2):257-272. PubMed ID: 31848873
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
Jing L; Li JX
Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
[TBL] [Abstract][Full Text] [Related]
7. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
[TBL] [Abstract][Full Text] [Related]
8. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
9. Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.
Liu JF; Siemian JN; Seaman R; Zhang Y; Li JX
J Neurosci; 2017 Jan; 37(4):882-892. PubMed ID: 28123023
[TBL] [Abstract][Full Text] [Related]
10. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.
Liu JF; Seaman R; Siemian JN; Bhimani R; Johnson B; Zhang Y; Zhu Q; Hoener MC; Park J; Dietz DM; Li JX
Neuropsychopharmacology; 2018 Nov; 43(12):2435-2444. PubMed ID: 29472642
[TBL] [Abstract][Full Text] [Related]
11. "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference.
Grandy DK; Miller GM; Li JX
Drug Alcohol Depend; 2016 Feb; 159():9-16. PubMed ID: 26644139
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
Pei Y; Mortas P; Hoener MC; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
[TBL] [Abstract][Full Text] [Related]
13. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
[TBL] [Abstract][Full Text] [Related]
15. Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization.
Wu R; Liu J; Wang K; Huang Y; Zhang Y; Li JX
Behav Brain Res; 2020 Jul; 390():112641. PubMed ID: 32407821
[TBL] [Abstract][Full Text] [Related]
16. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
18. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.
Achat-Mendes C; Lynch LJ; Sullivan KA; Vallender EJ; Miller GM
Pharmacol Biochem Behav; 2012 Apr; 101(2):201-7. PubMed ID: 22079347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
